CIP
BEAT

Chartwell Investment Partners’s BioTelemetry, Inc. BEAT Stock Holding History

Chartwell Investment Partners’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-27,992
Closed -$1.35M – 433
2019
Q2 		$1.35M Buy
27,992
+10,876
+64% +$572K 0.04% 361
2019
Q1 		$1.07M Buy
+17,116
New +$1.18M 0.03% 384

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RCAMU
Rothschild & Co Asset Management US Stamford, Connecticut $6.58B AUM 4.5% 1-Year Est. Return

Chartwell Investment Partners's BEAT Position: Q3 2019 in Review

Chartwell Investment Partners sold out of BioTelemetry, Inc. (BEAT) in Q3 2019, closing a stake of 27,992 shares — an estimated $1.35M sold.

Chartwell Investment Partners first reported a position in BEAT in Q1 2019 and held it in 2 quarters. The position peaked at $1.35M in Q2 2019. 219 funds tracked by Wall St. Rank hold BEAT as of Q3 2019.

  • Chartwell Investment Partners reported no remaining BioTelemetry, Inc. position as of Q3 2019 after selling out during the quarter.
  • Chartwell Investment Partners sold 27,992 BioTelemetry, Inc. shares in Q3 2019, an estimated $1.35M.
  • Chartwell Investment Partners first reported a position in BioTelemetry, Inc. in Q1 2019 and held it in 2 quarters.
  • Chartwell Investment Partners's BioTelemetry, Inc. position peaked at $1.35M in Q2 2019.
  • 219 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q3 2019.

Based on Chartwell Investment Partners's 13F filing for Q3 2019, filed 29 Oct 2019.